Literature DB >> 32208595

Mycobacterium caprae - the first case of the human infection in Poland.

Monika Kozińska1, Monika Krajewska-Wędzina2, Ewa Augustynowicz-Kopeć1.   

Abstract

The strain of tuberculous mycobacteria called <i>Mycobacterium caprae</i> infects many wild and domestic animals; however, because of its zoonotic potential and possibility of transmission between animals and humans, it poses a serious threat to public health. Due to diagnostic limitations regarding identification of MTB strains available data regarding the incidence of <i>M. caprae</i>, human infection does not reflect the actual size of the problem. Despite the fact that the possible routes of tuberculosis transmission are known, the epidemiological map of this zoonosis remains underestimated. The progress in diagnostic techniques, application of advanced methods of mycobacterium genome differentiation and cooperation between scientists in the field of veterinary medicine and microbiology, have a profound meaning for understanding the phenomenon of bovine tuberculosis and its supervise its incidence. This is the first bacteriologically confirmed case of human infection of <i>M. caprae</i> in Poland.

Entities:  

Keywords:  Mycobacterium bovis; Mycobacterium caprae; bovine tuberculosis; zoonosis

Mesh:

Year:  2019        PMID: 32208595     DOI: 10.26444/aaem/108442

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  2 in total

Review 1.  Selected Livestock-Associated Zoonoses as a Growing Challenge for Public Health.

Authors:  Kacper Libera; Kacper Konieczny; Julia Grabska; Wiktoria Szopka; Agata Augustyniak; Małgorzata Pomorska-Mól
Journal:  Infect Dis Rep       Date:  2022-01-13

2.  A case report of transmission and disease caused by Mycobacterium caprae and Mycobacterium bovis in Lima, Peru.

Authors:  Amber Shrestha; Janeth Picoy; Arturo Torres; David A Moore; Robert H Gilman; Jorge Coronel; Louis Grandjean
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.